Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Nope. They care about the share price and thats why they lie every now and then to pump for their buddies who help them keep the lights on! Its a vicious circle. No reason for LG to come on the Big Booz show and spew all the BS otherwise.
However, the market doesn’t trust them and therefore the pumps have been largely ineffective.
Yup, he goes on the block list along with his colleagues!
This number starts going up at a faster clip in the coming weeks! They know December is going to be a dud. It would be good to track.
Look who is saying this! Lets see what excuse December brings. Bunch of liars!
How did LG’s comment from 3 years go - UK approvals imminent? And LP’s comment at the same time - cant wait to release the data to the community in the coming weeks!
How do you defend that?
Haha, it must be irritating to do the dirty work of this management on a daily basis with the amount of lies they spew!
Will you stop posting if there is no final submission to MHRA by end of December? We can make a deal - flipper continues to post, but you stop posting instead! ;)
He/she is a know it all! Second trait is defending the management at all cost even if they flat out lie. Third he/she lives in denial!
Right, wait for another PR in late December or early Jan when they say they discovered something that needs to be addressed or however they word it! Pretty much guaranteed. Bunch of liars!
They are just lying, not so much a case of incompetence anymore. Because the excuses and the time this has taken is beyond the level of incompetence.
Months turned into 1.5 to 2 years with the TLD saga.
How about 2-3 weeks turning into several weeks?
Lets wait for another PR come mid-to-late December - we're working very very very hard on making some minor adjustments as quickly as we can. Or maybe this time around, they wont PR anything until they finally submit in Feb-March time frame.
Will you also stop posting if this doesn’t get submitted by the end of the year? ;)
Well, if you connect all the dots and their history as well as some hands on understanding of the regulatory applications, it becomes clear that its BS. You will see that they finally submit MAA in mid to late Q1. But again, the pumpers will say they will be applying to multiple regulators at once or back-to-back to justify this delay in the interim.
Ultimately when the only application that gets submitted in Q1 is to UK then folks will be disappointed yet again. The cycle will never end with this management team.
The combo discussion in their last quarterly report was likely a lie too to dangle another carrot.
The only thing they have going is the support of KOLs, which is why I am still around because I personally know couple of neurologists that collaborate with two of the neurosurgeons in the publication. However, most of these academic folks don't have an intricate understanding of the commercial and regulatory processes. So thats that!
My sense is they are going to get sued by some savvy shareholders that don't take BS. Its becoming more and more clear that they have been waiting for phase 2 combo data/study to complete and intentionally kept that info away from shareholders. Rather they kept deflecting to convince shareholders that its something or the other outside their control thats causing delays like the consultant story now….its all BS! Regulatory applications just don't take this long.
Flipper, you and I had that bet a few months ago. It was either you stop posting or I.
Well, we are not through the end of the year yet, but I will be sorry to see you go! I don’t know what your deal is but I know you’re extremely smart. Probably with a fantastic science/engineering background, but not so much real world and hands on commercial and regulatory experience?
I wish you success in your future endeavors!
Its best to block him, his aliases, and other pumpers. I don't respond to them. He mentioned multiple submissions by end of summer, not just one, LOL! They are just embarrassed with all the lies and fake timelines and then having to do the dirty work on behalf of the management.
Experts at moving the goal posts and deflecting. Its been ongoing for years!
Lets see. Its very likely we wont get NICE to approve reimbursements in 2024, but I expect UK approval by end of next year.
But all of this points to the fact that we will be trading well under a dollar for all of 2024 except for an occasional pump and dump cycle.
Agreed. They will only invest once they have solid confirmation of regulatory approval. Plus they are going to squeeze the hell out of this management and certainly not going to pay a premium over today’s trading price.
On the other hand, I do believe they will get approved in the UK by end of next year. Although it will be too little too late, IMHO.
You can multiply it by 100, but it ain’t happening in real world with this management. They will sell large number of C shares at under a dollar and throw the existing retail shareholders under the bus. Not the first time they will do that, but wait and watch. If it was within them they would have already done this massive dilution, but no investor wants to risk such a significant amount without getting solid confirmation on regulatory status.
They are also very good at moving the goal posts. Once MAA is submitted, acceptance of the application will be hyped and once that is done the expectations will be built around MHRA approvals….when nothing happens at that point in the second half of next year then the talks will move to FDA while the share price continues to languish under a dollar. We have a rich history of that with this management!
Markets will not give $3B valuation to NWBO with UK approvals alone given the history of this management. We don't know how reimbursements will be structured. UK is about 5% of the global pharma market.
The fact remains they would have taken almost 4 years from the data lock to secure UK approvals. Plus the market does not trust this management to scale quickly either.
However, one thing that is extremely likely is we will be at 1.5B outstanding shares by the time we receive UK approval. Therefore, we could be potentially trading lower than where we are currently if the approvals and reimbursements drag on for another year. Perhaps a pump and dump cycle in between, but ultimately it continues to trade well under a dollar.
Outside a big pharma $300-500M upfront cash investment, nothing will change meaningfully in terms of share price.
Buy the rumor sell the news, as they say! And shorts know this works like a charm with this management team. The market has no confidence in this management and they are unable to bring big, credible investors or big pharma on board….as OTC exchange excuses and victim card will always take center stage!
I have been saying this since spring when they didn’t submit immediately in the weeks following MIA in March. They had 30 months post data lock to prepare for the application already then and it was supposedly their number 1, 2, and 3 priority.
Having submitted multiple class II and III neurology medical devices through FDA and European regulatory agencies through my team, I know regulatory applications don't take this long regardless of how big or small your team is. Its the reimbursements that take forever but that is separate and we are not even discussing that yet!
Haha, they played the same game with TLD and publication for about 18 months! Bunch of liars!
Only management is to be blamed for not producing enough 3 years since data lock. They should have had FDA and UK approvals by now. And also if they had the goods, we would had a combo partnership with a major pharma paying $300-400M upfront cash.
Nothing will change in the next 6 odd months except MAA submission/acceptance, which shorts will take advantage of because there will be no follow through (good) news. Pumpers will complain about shorts as usual but never point fingers at the management. We will witness more of the same!
“They have the JAMA. They have LL on the SAB. They obviously have angle investors who are still willing (or dumb enough) to buy their BS.”
-I will tell you based on my experience working with KOL neurologists in the academia that they have limited understanding of the commercial side including regulatory efforts. Most of them will buy the BS the company feeds them. More importantly, they are extremely busy professionals, particularly neurosurgeons like LL, KA, et al. They have too many day-to-day things going on at their own centers including their routine surgical load amongst dozens of other things as well as developing new programs, grants, projects, etc that they hardly get time to think about this on a weekly/monthly basis as some of us do.
On the other hand, I suspect many angel (savvy) investors know whats going on and are using the inside information to trade and make a ton of money….they are obviously going to defend the management at all cost otherwise they stop receiving inside info!
They want people to believe that submission timing is outside their control. In reality, they are intentionally delaying it until phase 2 combo study is completed by end of January. I continue to believe there will be no submission until February at the earliest.
And if there is indeed no submission until Feb, watch out for another lawsuit on the management.
Lol, nothing can be more stupid than the excuse they already gave us last month, particularly 3 years after data lock.
Another reason pumpers will use to justify the delay in UK submission thats coming up in a couple of weeks!
2024 will be another lost year for shareholders. And it will be over 4 years since data lock then. No meaningful revenue from UK, no FDA approval, no combo partnership with big pharma….But the pumpers will still be pumping about $5-10 share price coming soon to keep shareholders on the hook!
And all this while management will continue to dilute C shares at under a dollar and continue to spew lies!
“The science will overcome the incompetence eventually.“
- its not just the incompetence and lethargy thats bothersome, but more importantly their ethics. They continue to lie to shareholders and treat us stupid.
Otherwise, I agree that KOLs supporting the technology is what will carry this to approvals eventually. However, this may not necessarily translate to big returns that many here are expecting with this management outside a big pharma involvement. The shorts will continue to take advantage whenever this management puts out a PR because they know this team is not capable of following through and scaling this expeditiously in the near to mid future…and therefore no big pharmas or big, credible investors are going to get involved any time soon either…
“The conversations of Cs that people hold and this last loan I would “hope” brings them into a substantial revenue period.”
- you forget the same was assumed for the last 2-3 loans since data lock. Then publication + TLD PR coupled with Specials revenue was going to significantly improve our cash situation. We are almost 18-24 months since then.
I hate to break your bubble, but the commercial revenue in 2024 will be insignificant. In fact, they will not break even in 2024 because the investments needed on manufacturing and operations will be greater than the profits. The same conservations will continue the rest of 2024 and folks will be disappointed when its all said and done.
You seem to be living in denial mode. I want shorts to get screwed, but the history of this management in the last 15 years suggest they will continue to disappoint. Lets review this thread in Q1 next year when the MAA is finally submitted, but share price is still languishing under a dollar. I repeat there will be no combo deals. Its all a lie!
Yup. They will continue to slowly dilute the C shares in 2024 to keep the lights on.
Agreed. Another excuse will come in a couple of weeks.
Also, there will be no big combo partnership deals anytime soon. They have been lying on that front too. Just like how their social media army were creating false expectations that floodgates will open when peer reviewed publication and TLD PR comes out! It wouldn’t be surprising if there is a sell off post MHRA submission because there are no combo deals in sight.
It means prepare for another delay. It was so obvious with all the pump that another take down was coming. Do the opposite of what known pumpers put out in social media and you will do well! ;)
Shows why LP hasn’t been able to build an A team or bring big investors on board. If she cannot build enough excitement to hire a top notch executive or investors particularly after JAMA last year then she doesn't deserve to lead this company.
BS! Still no reason to keep lying LG on your team. Did they give up 10% equity when they hired Dr. George recently or Duffy a few years ago? That would make LP a bad negotiator.
And all this talk about big pharma partnership(s) is likely another lie by management to pump and dump a large number of C shares on the upcoming news cycle. I doubt a BP gets involved with the history of this management team. There will be another excuse in a few weeks, just wait and watch!
LG is a liar! That fact that NWBO continues to have him serve as SVP of the Business Development is a shame! Even if you sideline all his lies at the Big Booz show over the years, how can a 80+ year old still be the head of business development of a billion dollar market cap company? A well run and managed board/company would never allow that.
“Still I don’t think Bio is right or we wouldn’t have GBM patients from the UK rattling the can for donations as one post yesterday showed, they would be talking about how NWBO generously helped them.“
Correct, they are probably treating less than 10 patients per quarter at the max. That is also being very generous! Both Bio & Zivic are known pumpers!
I’d be happy to disappear if they submit in November and the share price doubles or triples from here and stay there. But thats wishful thinking with this management! They do find unique ways to screw retail and then use their social media army to blame it on shorts.